people

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment

BOSTON† June 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, announced today that the European Commission (EC) this week authorized a variation for IMCIVREE (setmelanotide) that allows for dosing in patients with POMC or LEPR …

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment Read More »

Opinion: Forget swimming pools – give me a cold lake any day of the week

Opinion: Forget swimming pools – give me a cold lake any day of the week

An open water swimmer on the return leg while swimming in Lake Ontario.Fred Lum/the Globe and Mail Kathleen McDonnell is the author of Growing Old, Going Cold: Notes on Swimming, Aging and Finishing Last, from which this essay is adapted. Back in early 2020, there was a brief period when it looked like the pandemic …

Opinion: Forget swimming pools – give me a cold lake any day of the week Read More »